These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26071831)

  • 21. Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosis.
    Terry CM; He Y; Cheung AK
    Thromb Res; 2016 Aug; 144():106-12. PubMed ID: 27318247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early recanalization of veins in patients with DVT treated with rivaroxaban: do we need to move from bedside to bench again?
    Ramacciotti E; Volpiani GG; Dávila R; Resende Aguiar VC; Silveira Magella FM; Fareed J
    Int Angiol; 2018 Feb; 37(1):1-3. PubMed ID: 28945062
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of Rivaroxaban for Mesenteric Vein Thrombosis Secondary to Diverticulitis: A Case Report.
    Parthvi R; Mehra S
    Am J Ther; 2017; 24(5):e629-e630. PubMed ID: 27759584
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombosis in Fontan patient on apixaban.
    Pinto C; Samuel BP; Ratnasamy C; Vettukattil JJ
    Int J Cardiol; 2015 Mar; 182():66-7. PubMed ID: 25590960
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-vitamin K antagonist oral anticoagulants (NOACs) in the cardiac catherisation laboratory: Friends or Foes?
    Htun NM; Peter K
    Thromb Haemost; 2015 Aug; 114(2):214-6. PubMed ID: 25995026
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement of distal acquired demyelinating symmetric (DADS) neuropathy after exposure to factor Xa inhibitor.
    Lizarraga AA; Cochrane TI; Berkowitz AL
    J Neurol Sci; 2018 May; 388():146-149. PubMed ID: 29627010
    [No Abstract]   [Full Text] [Related]  

  • 27. Rivaroxaban in atrial fibrillation cardioversion: insights from the X-VeRT trial.
    Farag M; Gorog DA
    Future Cardiol; 2015 Mar; 11(2):147-51. PubMed ID: 25760874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device.
    Cohen D
    BMJ; 2015 Dec; 351():h6431. PubMed ID: 26635138
    [No Abstract]   [Full Text] [Related]  

  • 29. Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
    Theberge I; Bowdridge J; Forgie MA; Carrier M; Louzada M; Siquiera L; Rhodes M; Wells PS
    Thromb Res; 2017 Apr; 152():4-6. PubMed ID: 28192715
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
    Lefaucheur R; Le Goff F; Gaillon G; Triquenot-Bagan A; Maltête D
    Presse Med; 2015 Nov; 44(11):1203-4. PubMed ID: 26433836
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.
    Barón-Esquivias G; Fernández-Avilés F; Atienza F; Pastor Pueyo P; Toro R; Sanmartín Fernández M
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):341-53. PubMed ID: 25797900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case series of recalcitrant livedoid vasculopathy treated with rivaroxaban.
    Lee JM; Kim IH
    Clin Exp Dermatol; 2016 Jul; 41(5):559-61. PubMed ID: 26993107
    [No Abstract]   [Full Text] [Related]  

  • 33. Web Exclusives. The Consult Guys--VTE: Is There Cancer?
    Merli GJ; Weitz HH
    Ann Intern Med; 2016 Jan; 164(2):CG1. PubMed ID: 26784488
    [No Abstract]   [Full Text] [Related]  

  • 34. July 2015 at a glance.
    Metra M
    Eur J Heart Fail; 2015 Jul; 17(7):641. PubMed ID: 26139581
    [No Abstract]   [Full Text] [Related]  

  • 35. Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia.
    Hantson P; Lambert C; Hermans C
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):205-6. PubMed ID: 25255239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivaroxaban for Treatment of Pulmonary Embolism While Receiving Electroconvulsive Therapy.
    Shao E; Moore R; Linnane J
    J ECT; 2017 Sep; 33(3):e25-e26. PubMed ID: 28198719
    [No Abstract]   [Full Text] [Related]  

  • 37. Congenital protein C deficiency and thrombosis in a dog.
    Kelly D; Juvet F; Moore G
    J Vet Intern Med; 2020 May; 34(3):1300-1303. PubMed ID: 32277743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New Anticoagulants in the Treatment of Patients With Recent Acute Coronary Syndrome. Place of Rivaroxaban].
    Hirmanov VN
    Kardiologiia; 2015; 55(6):98-104. PubMed ID: 26625526
    [No Abstract]   [Full Text] [Related]  

  • 39. First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.
    Ng HJ; Than H; Teo EC
    Thromb Res; 2015 Jan; 135(1):205-7. PubMed ID: 24974053
    [No Abstract]   [Full Text] [Related]  

  • 40. Livedoid vasculopathy in Koreans: clinical features and response to rivaroxaban treatment.
    Lee JS; Cho S
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):e176-e178. PubMed ID: 31793049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.